drugset / Trial / NCT06784882

Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee Arthroplasty

NCT06784882 ↗

Phase 4 Recruiting 40 enrolled University of California, San Diego
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a single-center pilot study to determine if an adductor canal continuous nerve block is superior to single injection nerve block following total knee arthroplasty. Investigators will randomize participants to either continuous nerve block or single injection nerve block for the adductor canal preoperatively. They will assess differences in pain (measured in numeric rating scale), opioid consumption, and physical therapy milestones from postoperative day 0 to 7.

Timeline

Start
2025-06-01
Primary completion
2025-12-01
Completion
2025-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ropivacaine Other / unclassified 0.2 % Other
Comparator Ropivacaine Other / unclassified 0.5 % Other
Comparator Lidocaine Other / unclassified — —

Indications

No indication recorded.